Table 3.

Table showing the year after the vaccination program starts in which the decline of oncogenic HPV reaches 65%, 75%, 85%, and 95% when vaccinating boys and girls with 75% and 90% coverage. MSM are included in men, and are also considered separately. The symbol “−” means that this percentage of decline was not reached during the simulation period.

Vaccination of Boys and Girls with 75% Coverage
Decline	Women	Men	MSM
65%	year 26 95% CI (20, 39)	year 31 95% CI (20, 40)	year 37 95% CI (34, 41)
75%	year 34 95% CI (22, 42)	year 38 95% CI (24, 44)	year 45 95% CI (41, 51)
85%	year 42 95% CI (25, 46)	year 46 95% CI (34, 48)	year − 95% CI (–, –)
95%	year – 95% CI (52, –)	year – 95% CI (–, –)	year – 95% CI (–, –)
Vaccination of Boys and Girls with 90% Coverage
Decline	Women	Men	MSM
65%	year 24 95% CI (19, 38)	year 27 95% CI (19, 38)	year 31 95% CI (28, 34)
75%	year 30 95% CI (21, 42)	year 33 95% CI (22, 40)	year 36 95% CI (33, 39)
85%	year 38 95% CI (24, 44)	year 40 95% CI (25, 44)	year 42 95% CI (39, 44)
95%	year 46 95% CI (34, 48)	year 47 95% CI (40, 49)	year – 95% CI (48, –)